Anu Anttonen
Papers
1
Total Citations
18
H-Index
1
About
Anu Anttonen is a leading figure in the advancement of boron neutron capture therapy (BNCT), a targeted form of radiation oncology. Her key research areas center on the clinical translation and optimization of BNCT, particularly for treating malignant brain tumors, head and neck cancers, and other difficult-to-treat malignancies. Anttonen’s major contribution is her comprehensive review of the Finnish BNCT experience, which documents the outcomes of 249 patients treated at Helsinki University Hospital between 1999 and 2012. This landmark study, with 18 citations, provides critical long-term data on the efficacy and safety of using a nuclear reactor-based neutron source with l-boronophenylalanine-fructose (l-BPA-F) as the boron carrier. Her work has been instrumental in demonstrating the clinical feasibility of BNCT and in shaping the transition from reactor-based to proton accelerator-based neutron sources, a pivotal shift that promises wider accessibility and improved treatment precision. Anttonen’s research remains a cornerstone for clinicians and scientists working to bring this innovative therapy into mainstream cancer care.
Research Focus
Key Achievements
Top Papers
- 1